Craig Asher
InvestorManaging Director at OMX Ventures
Washington, District of Columbia
Writes $500K β $15M checks Β· typically $7.8M
About
Craig Asher is a co-founder and managing partner of OMX Ventures, which he helped form in 2020. He previously worked as an early-stage biotech investor from 2009 to 2020, backing companies including QuantaLife, 10X Genomics, Twist Bioscience, Ginkgo Bioworks, and CD Diagnostics. Earlier in his career he worked as a manufacturing engineer and held roles at Trigo Technologies (later IBM), and he holds a degree from Stanford University plus an MBA and MS in Industrial Engineering from Northwestern University.
Invests in
Biotech
Experience
- OMX VenturesManaging Directorcurrent2020 β presentWashington, District of Columbia, United States
- Syndex BioBoard Observercurrent2025 β presentCambridgeshire, England, United Kingdom
- Constructive BioBoard Observercurrent2022 β presentCambridgeshire, England, United Kingdom
- Glyphic BiotechnologiesBoard Membercurrent2021 β presentSan Francisco Bay Area
- VedaBioBoard Membercurrent2021 β presentSan Diego, California, United States
- MatterworksBoard Membercurrent2020 β presentBoston, Massachusetts, United States
- Lightcast DiscoveryBoard Observercurrent2021 β presentCambridge, England, United Kingdom
- Merieux Equity PartnersStrategic Advisorcurrent2020 β present
- Aperiam BioBoard Observercurrent2022 β presentAustin, Texas, United States
- Menlo MicroBoard Observercurrent2016 β presentOrange County, California, United States
- Tessera TherapeuticsInvestorcurrent2020 β presentBoston, Massachusetts, United States
- Trancos VenturesManaging Partnercurrent2016 β presentWashington DC-Baltimore Area
- CircadenceBoard Membercurrent2012 β presentBoulder, CO
- Hexagon BioInvestorcurrent2017 β presentSan Francisco Bay Area
- Delix TherapeuticsInvestorcurrent2019 β presentBoston, Massachusetts, United States
- ManusInvestorcurrent2017 β presentPleasanton, California, United States
- 10x GenomicsInvestorcurrent2012 β presentPleasanton, California, United States
- SyntheX, Inc.Investorcurrent2017 β presentSan Francisco, CA
- Vital Venture Capital LLCPrincipalcurrent2008 β presentWashington DC-Baltimore Area
- ReplayInvestor2022 β 2026San Diego, California, United States
Education
- Northwestern UniversityMS, Industrial Engineering1993 β 1994
- Northwestern University - Kellogg School of ManagementMaster of Business Administration - MBA, Marketing1991 β 1993
- Stanford UniversityAB, Political Science1984 β 1988
- Heidelberg UniversityPolitischewissenschaft1988
- New Trier High1981 β 1984
Skills & more
+12 more
Strategic PartnershipsEntrepreneurshipGo-to-market StrategyExecutive ManagementCloud ComputingCompetitive AnalysisMobile DevicesTelecommunicationsE-commerceAnalyticsDue DiligenceMergers & AcquisitionsLanguages English Β· French Β· German Β· Italian Β· Spanish
From Craig's professional profile.
Same school
Also attended Northwestern University288
+ 282 more
Also attended Northwestern University - Kellogg School of Management521
+ 515 more
Also attended Stanford University1,726
+ 1,720 more
Also attended Heidelberg University33
+ 27 more
Shared employers
Also worked at Lightcast Discovery6
Also worked at Menlo Micro7
+ 1 more
Also worked at Halfpenny Technologies2
Also worked at Booker Software2
Investments
Investor
10X GenomicsCD DiagnosticsGinkgo BioworksQuantaLifeTwist Bioscience
Per the firm's website.
Colleagues at OMX Ventures
Network1
Investors connected to Craig in public investor directories β a warm-intro map.








































